We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Noninvasive Prenatal Test Launched

By LabMedica International staff writers
Posted on 21 May 2012
Print article
An innovative noninvasive test detects common fetal trisomies utilizing a directed approach to analyze cell-free DNA (cfDNA) in maternal blood.

The test is performed using a simple maternal blood draw taken at a doctor's office or patient service center, and provides the safety of screening tests with accuracy approaching that of invasive testing for common fetal trisomies.

The Harmony Prenatal Test, which detects common fetal trisomies such as Trisomy 21 which is associated with Down syndrome, will be offered through Laboratory Corporation of America Holdings (LabCorp, Burlington, NC, USA) and will be available at its more than 1,000 patient service centers. The test is available to pregnant women of at least 10 weeks gestational age with a single fetus conceived without the use of an egg donor.

The Harmony Prenatal Test will be available in the United States and Canada through Integrated Genetics, a member of LabCorp's Specialty Testing Group. The test is a product of the molecular diagnostics company Ariosa Diagnostics (San Jose, CA, USA). Compared to random sequencing, directed cfDNA analysis is simpler, less costly, and more precise. It also provides individualized prenatal test results for trisomy risk.

Ken Song, MD, chief executive officer at Ariosa Diagnostics, said, "Ariosa Diagnostics is very excited to announce the official launch of the Harmony Prenatal Test and the agreement with LabCorp, which helps us deliver on the promise of bringing an affordable and accessible prenatal testing option to pregnant women and their physicians. With enhanced test performance and simplicity, the Harmony Prenatal Test can be reliably incorporated into the management of pregnancies."

Mark Brecher, MD, LabCorp's chief medical officer, added, "We are pleased to be able to offer this novel, noninvasive prenatal test. Ariosa Diagnostics' Harmony Prenatal Test adds another option to LabCorp's comprehensive prenatal testing menu." Integrated Genetics is a business unit of Esoterix Genetic Laboratories (Austin, TX, USA), a wholly-owned subsidiary of Laboratory Corporation of America Holdings.

Related Links:

Laboratory Corporation of America Holdings
Ariosa Diagnostics
Esoterix Genetic Laboratories



New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
DNA topoisomerase I ELISA
Anti-Scl-70 ELISA Test
New
Control Material
Blood Culture Identification Control Panel

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.